Here’s what the first mRNA flu vaccine could mean for flu season

Moderna has developed mFlusiva, the first mRNA-based flu vaccine. Science News reports that the vaccine generates stronger, longer-lasting immunity and is more effective at preventing infection compared with standard flu shots, according to available data.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton